Tests tirzepatide

Every paper here, unless its row says otherwiseTests tirzepatide; returned by a PubMed search for tirzepatide

• Comparative efficacy of tirzepatide and glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes: a systematic review and network meta-analysis.

  Cardiovascular diabetology2026PMID 41761267

• Weight Changes With Tirzepatide and Concomitant Weight-Inducing Medications: Post Hoc Analysis of Randomized Clinical Trials.

  JAMA network open2026PMID 41885866

• The adverse effects associated with tirzepatide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis.

  BMC medicine2026PMID 41896878

• Cardiovascular Outcomes With Tirzepatide Versus GLP-1 Receptor Agonists in Overweight or Obesity: A Systematic Review and Meta-Analysis.

  Diabetes, obesity & metabolism2026PMID 42410309

• Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists.

  Diabetes, obesity & metabolism2026PMID 42420795Tests tirzepatide

• Comparative Efficacy and Safety of Tirzepatide in Asian and Non-Asian Adults With Obesity Without Diabetes: A Systematic Review and Meta-Analysis.

  Endocrinology, diabetes & metabolism2026PMID 42487213

• Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials.

  Endocrinology, diabetes & metabolism2026PMID 42706739

• Tirzepatide and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis.

  Endocrinology and metabolism (Seoul, Korea)2025PMID 39814031

• Effects of Tirzepatide in Type 2 Diabetes: Individual Variation and Relationship to Cardiometabolic Outcomes.

  Journal of the American College of Cardiology2025PMID 40368575

• Weight Loss Efficacy of Tirzepatide Compared to Placebo or GLP-1 Receptor Agonists in Adults With Obesity or Overweight: A Meta-Analysis of Randomized Controlled Trials With ≥ 20 Weeks Treatment Duration.

  Journal of obesity2025PMID 40746703

• Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis.

  Frontiers in endocrinology2025PMID 40747302

• Tirzepatide for adults living with obesity.

  The Cochrane database of systematic reviews2025PMID 41161687

• Evidence that tirzepatide protects against diabetes-related cardiac damages.

  Cardiovascular diabetology2024PMID 38555463

• Efficacy and safety of once-weekly tirzepatide for weight management compared to placebo: An updated systematic review and meta-analysis including the latest SURMOUNT-2 trial.

  Endocrine2024PMID 38850440

• Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.

  Diabetologia2022PMID 35579691